UCSF at #AACR25: Laura Huppert, MD | Liquid Biopsy: Circulating Tumor Cells Learn more in
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1026. ©2025 American Association for Cancer Research. Envisioning Innovation Through Cross-disciplinary Team Science
Dr Nilsson talks to ecancertv at AACR 2015 about the development of a blood test which regularly monitors for the presence of the Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer care.
David Polsky MD,PhD Professor of Cutaneous Oncology at NYU discusses the role of Circulating Tumor DNA and Liquid Biopsy This conference brings together leaders in the field to share the latest advancements in liquid biopsies encompassing the spectrum from discovery to clinical Visit for more. Prof Gordon McVie of ecancer summarises the highlights of the 26th EORTC-NCI-AACR
April 2025. Rensheng Wan, a postdoctoral scholar in Dr. David Quigley's lab at UCSF, presented herwork on using methylation Inocras AACR 2025 MRD The American Association for Cancer Research released its annual Cancer Progress Report – cancerprogressreport.org – at a
Will liquid biopsy replace traditional diagnostic tools? Highlights the most recent research efforts presented at the AACR Annual Meeting 2025, focusing on liquid biopsy (LB) methods and applications.
AACR Workshop: Ultra-low Input Targeted Genomic Analysis for Pancreatic Cyst Lesions and Cancer Andrew Rhim, M.D., Assistant Professor of Internal Medicine and Assistant Director for Translational Research, University of AACR Exhibitor Spotlight
The lack of common standards creates a major obstacle for the broader use of liquid biopsies in clinical settings. Dr. Thomas Hot Topics at AACR 2018 with Dr. Elaine Mardis
Improving the selection process for adjuvant checkpoint inhibition Hear from Prof. Nir Peled, an eminent oncologist from Israel, as he shares his views on the important role of liquid biopsy in The benefits of liquid biopsies for lung cancer in the community setting
Cancer in a Drop: Liquid biopsy insights from AACR 2025. AACR Grant Propels Progress in Pancreatic Cancer Research The AACR Special Conference on Advances in Liquid Biopsies ( held January 12-16, 2020 in Miami,
During the 2019 AACR Annual Meeting, Vassiliki Papadimitrakopoulou, MD, professor of medicine, Department of Thoracic/Head Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, discusses the clinical relevance of
Research presented at the AACR Annual Meeting 2021 highlights the great potential of liquid biopsy to benefit patients across the April 21, 2025. Laura Huppert, a breast medical oncologist at UCSF, will be presenting "Development of a novel assay to detect The AACR Cancer Progress Report 2018 highlights how research discoveries are driving progress through the development of
Simultaneously isolating cfDNA and Circulating tumor cells (CTCs) from a Single Sample | AACR 2015 Challenges to implementing liquid biopsy in clinical practice
AACR 2018 QIAGEN boothtour with Lee-Anne Dr. Stefanie Jeffery: Integration of Liquid Biopsy into Clinical Cancer Care
Cancer in a Drop: Liquid biopsy insights from AACR 2025 Stanford Surgery's Chief of Surgical Oncology Research discusses the past and future of liquid biopsy. For more information about
Researching Liquid Biopsy in Cancer Care New findings on the utility of circulating biomarkers for liquid biopsy
The future of liquid biopsies in head and neck cancer Mouadh Barbirou, PhD, Thomas Jefferson University, Philadelphia, PA, examines the epigenomic and genomic profiles of tumor
Arpit Rao, MD, University of Minnesota, Minnesota, MN, talks on the clinical utility of liquid biopsies in prostate cancer, which Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, outlines the main challenges for A Liquid Biopsy-based Assay Could Detect Recurrence Prior to
Inocras introduces clinical validation of their MRDVision assay. MRDVision is a whole-genome based, panel-free, tumor-informed UCSF at #AACR25: Rensheng Wan, PhD, on Women in Cancer Research Award and Mentorship Opportunities This talk highlights two different oncology research applications for Roche's Digital LightCycler® dPCR System. First, Yu Zhao
Webinar: Stephen Bagley, MD - Liquid Biopsy for Brain Tumors: Recent Advances and Future Directions Earn CME credit for a related activity: In this presentation from Lymphoma & Myeloma 2018, Dr.
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6372. ©2025 American Association for Cancer Research. Cancer in a Drop: Liquid biopsy insights from AACR 2025 - PMC
ROME: integrating tissue and liquid biopsies in precision oncology Molecular profiling of tumor biomarkers in head and neck cancer The liquid biopsy has the potential to change cancer research and clinical care through a variety of applications, from early
Stephen Bagley, MD, MSCE, Assistant Professor of Medicine at the University of Pennsylvania, provides an overview of the A career development grant from the AACR initiated the development of a model to help understand one of the deadliest and most Leveraging Liquid Biopsy to Improve Cancer Care | Blog | AACR
Abstract 6372: Combined tissue and liquid biopsy improves AACR 2024: An exosome-based liquid biopsy shows promise for
Policy Briefing: AACR Cancer Progress Report 2022 Martha Chekenya, PhD, University of Bergen in Bergen, Norway, discusses the next steps following the Phase I/II clinical trial
Identifying molecular biomarkers for treatment response to bortezomib in glioblastoma Program Precision Med 2020 | Meetings | AACR
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA Panel examines emerging clinical applications of liquid biopsy The Important Role of Liquid Biopsy in Clinical Practice
This Special Conference will be unique as it is the first program designed to address traditional cancer research topics such as trial design, diagnostics, Ezra Cohen, MD, FRCPSC, FASCO, Moores Cancer Center at UC San Diego Health, San Diego, CA, comments on how liquid
Highlights of the EORTC-NCI-AACR Symposium Klaus Pantel, Chairman of the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf, reviews how liquid AACR 2018 - Thomas Schlange about the CANCER-ID initiative
Promising new circulating biomarkers for liquid biopsy Liquid biopsy in daily clinical practice
Potential trends in the molecular profiling of breast cancer Mouadh Barbirou, PhD, Thomas Jefferson University, Philadelphia, PA, provides an overview of remaining hurdles in
Abstract 1026: Multi-modal liquid biopsy analysis of early-stage Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, outlines the different circulating
While tissue biopsies remain the gold standard of cancer diagnostics, liquid biopsy More from the AACR Annual Meeting 2025 · View a photo Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
Liquid Biopsy in Cancer Care Genomics 101: From deep sequencing to liquid biopsies AACR 2024 Spotlight Theater
AACR 2009: Circulating tumour cells as biomarkers In this interview André de Fusco and Dr. Paul Dempsey (CEO and CSO of Cynvenio Biosystems Inc.) share their perspective on An ultrasensitive ctDNA-based liquid biopsy assay detected signs of recurrence prior to imaging and provided prognostic value within one
AACR 2021 Product Demo: Overview of ImmunoID NeXT Platform. Prof Klaus Pantel presents at ecancer's Milan Summit on Precision Medicine 2018 about the potential advances in liquid biopsy Alain Thierry, PhD, INSERM U896 - IRCM, Montpellier, France, briefly comments on the breakthrough role of liquid biopsy
Researchers are finding innovative ways turn the great potential of liquid biopsy into real benefit for patients across the continuum Deepti Behl, MD, Sutter Sacramento Medical Center, Sacramento, CA, comments on the role of liquid biopsies for lung cancer.
Challenges in implementing liquid biopsies for head and neck cancer Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, talks on whether liquid biopsies Challenges in Liquid Biopsy
The American Association for Cancer Research exhibit hall debuted the new LiquidBiopsy™ Platform, and in this video Vidya What is the LiquidBiopsy Platform? - AGBT 2015
Paolo Marchetti, MD, PhD, IDI-IRCCS, Rome, Italy, discusses the potential of combined biopsy approaches in advanced tumor Clinical utility of liquid biopsies in prostate cancer
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Paolo Marchetti, MD, PhD, IDI-IRCCS, Rome, Italy, discusses an analysis from the ROME trial (NCT04712864), which evaluated American Association for Cancer Research President Elaine R. Mardis, PhD, FAACR, discusses the importance of federal Jason Johnson of Thermo Fisher Scientific talks about finding circulating tumor cells with as few as 20 cells with the LiquidBiopsy
Liquid Biopsy 2024 | Meetings | AACR AACR 2021 Product Demo Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
Dr. Elaine Mardis, chair of this year's AACR Program Committee, talks about the hot topics for AACR 2018, technological hurdles Liquid biopsies for the detection of precancerous lesions
AACR Cancer Progress Report 2018 Congressional Briefing The Promise of Liquid Biopsy Advances in Liquid Biopsies
cfDNA & CTC by the LiquidBiopsy Platform | AACR 2015 Dr Howard I. Scher, Chief, Genitourinary Oncology Service; D. Wayne Calloway Chair in Urologic Oncology, Sloan Kettering Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky
Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, summarises the recent updates on Sofia Mastoraki, PhD, University of Texas MD Anderson Cancer Center, Houston, TX discusses molecular profiling and the need
Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, the possible clinical applications of Integrating tissue and liquid biopsies in solid tumor management
QIAGEN's Lee-Anne Zinetti walks through QIAGEN's Sample to Insight offering at AACR 2018 and explains what the company Highlighting the Clinical Utility of Liquid Biopsies for Biomarker Detection in NSCLC Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on combining tumor-specific